Thalidomide Lipomed
What Thalidomide Lipomed is used for
Thalidomide Lipomed in combination with melphalan and prednisone is indicated as first line treatment of patients with untreated multiple myeloma, aged … (the exact criteria are in the official EMA product information).
Approved use, as published by the European Medicines Agency.
Key facts
- Brand
- Thalidomide Lipomed
- Active substance
- thalidomide
- Disease area
- Multiple Myeloma
- Medicine group
- Immunosuppressants
- ATC code
- L04AX02
- Marketing authorisation holder
- Lipomed GmbH
- Authorised in the EU since
- 2022
Official information
In India
- Thalidomide: 31 brands in India
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Thalidomide Lipomed used for?
Thalidomide Lipomed in combination with melphalan and prednisone is indicated as first line treatment of patients with untreated multiple myeloma, aged … (the exact criteria are in the official EMA product information).
What is the active substance in Thalidomide Lipomed?
Thalidomide Lipomed contains thalidomide.
Who makes Thalidomide Lipomed?
The EU marketing authorisation holder is Lipomed GmbH.
Source: European Medicines Agency medicines data (ema.europa.eu), reproduced with acknowledgement of the source. Page made 5 November 2026 by Satya Babu.
← All specialty medicines, EU